Calithera Biosciences (CALA)
(Delayed Data from OTC)
$0.05 USD
0.00 (0.00%)
Updated Sep 13, 2024 02:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Calithera Biosciences, Inc. [CALA]
Reports for Purchase
Showing records 21 - 26 ( 26 total )
Company: Calithera Biosciences, Inc.
Industry: Medical - Drugs
Company: Calithera Biosciences, Inc.
Industry: Medical - Drugs
ASCO Data Suggest CB-1158 Acts as It''s Supposed to; Raising PT to $19 From $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Calithera Biosciences, Inc.
Industry: Medical - Drugs
Adding CB-1158 and Accounting for Dilution Yields Higher $14 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Calithera Biosciences, Inc.
Industry: Medical - Drugs
Incyte Partnership Provides Validation, Funding for CB-1158; Raising PT to $10 From $9
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Calithera Biosciences, Inc.
Industry: Medical - Drugs
Starve a Tumor, Feed an Immune Cell; Initiating Coverage With a Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Calithera Biosciences, Inc.
Industry: Medical - Drugs
Sector Analysis, Initiating Dawson James Sector Indices: Rare Diseases/Neuro-oncology
Provider: DAWSON JAMES SECURITIES, INC.